TITLE

Immunological Approaches to Prevent Neuronal Apoptosis During Neuroinflammation

AUTHOR(S)
Murphy, F. J.; Keating, K. E.; Sheehan, D.; Hayes, I.
PUB. DATE
August 2005
SOURCE
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy A;Aug2005, Vol. 4 Issue 4, p367
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Neurodegeneration is set to increase in parallel with society's age demographics. With the increasing appreciation of the role played by apoptosis in neurodegeneration, much effort has gone into understanding key effectors in this process and to develop therapies that reduce neuronal apoptosis, thus preserving the integrity of the CNS. In contrast to peripheral apoptosis, inflammation is commonly seen to co-localize with apoptotic sites in the CNS however investigators are unsure whether inflammation is the primary cause for neuronal apoptosis induction or whether it is secondary. This current review highlights the role of apoptosis in neurodegenerative diseases, examines the evidence as to whether inflammation is a causative or consequential event in neuronal apoptosis and describes some of the immunological approaches that are currently in the clinic or being developed.
ACCESSION #
17740828

 

Related Articles

  • Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity. Dodge, James C.; Haidet, Amanda M.; Yang, Wendy; Passini, Marco A.; Hester, Mark; Clarke, Jennifer; Roskelley, Eric M.; Treleaven, Christopher M.; Rizo, Liza; Martin, Heather; Kim, Soo H.; Kaspar, Rita; Taksir, Tatyana V.; Griffiths, Denise A.; Cheng, Seng H.; Shihabuddin, Lamya S.; Kaspar, Brian K. // Molecular Therapy;Jun2008, Vol. 16 Issue 6, p1056 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. Recent work in rodent models of ALS has shown that insulin-like growth factor-1 (IGF-1) slows disease progression when delivered at disease onset. However, IGF-1's mechanism of action along the...

  • Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke. Maples, Kirk R.; Green, A. Richard; Floyd, Robert A. // CNS Drugs;2004, Vol. 18 Issue 15, p1071 

    At present, none of the neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease and stroke are treatable with compounds that slow or halt neuronal cell death. However, the prototype nitrone radical trap alpha-phenyl-tert-butylnitrone (PBN) has been shown to be an effective...

  • Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Pluchino, Stefano; Zanotti, Lucia; Rossi, Barbara; Brambilla, Elena; Ottoboni, Linda; Salani, Giuliana; Martinello, Marianna; Cattalini, Alessandro; Bergami, Alessandra; Furlan, Roberto; Comi, Giancarlo; Constantin, Gabriela; Martino, Gianvito // Nature;7/14/2005, Vol. 436 Issue 7048, p266 

    In degenerative disorders of the central nervous system (CNS), transplantation of neural multipotent (stem) precursor cells (NPCs) is aimed at replacing damaged neural cells. Here we show that in CNS inflammation, NPCs are able to promote neuroprotection by maintaining undifferentiated features...

  • Inflammation and degeneration in multiple sclerosis. Brück, W.; Stadelmann, C. // Neurological Sciences;Dec2003 Supplement 5, Vol. 24, ps265 

    Multiple (MS) sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with the pathological hallmarks of inflammation, demyelination, axon loss and gliosis. In the initial relapsing-remitting phase of the disease, the inflammatory-demyelinating component seems to...

  • Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Andersen, Hjalte; Johnsen, Kasper; Moos, Torben // Cellular & Molecular Life Sciences;May2014, Vol. 71 Issue 9, p1607 

    Neurodegenerative disorders are characterized by the presence of inflammation in areas with neuronal cell death and a regional increase in iron that exceeds what occurs during normal aging. The inflammatory process accompanying the neuronal degeneration involves glial cells of the central...

  • Hemichannels in neurodegenerative diseases: is there a link to pathology? Bosch, Megan; Kielian, Tammy // Frontiers in Cellular Neuroscience;Jul2014, preceding p1 

    Although originally considered a structural component of gap junctions, connexin hemichannels (HCs) are now recognized as functional entities capable of influencing metabolic gradients within the CNS, allowing direct communication between the intra- and extracellular milieus. Besides connexins,...

  • Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice. Anderson, Sarah; Lee, Inyoul; Ebeling, Christine; Stephenson, Dennis; Schweitzer, Kelsey; Baxter, David; Moon, Tara; LaPierre, Sarah; Jaques, Benjamin; Silvius, Derek; Wegner, Michael; Hood, Leroy; Carlson, George; Gunn, Teresa // Mammalian Genome;Feb2015, Vol. 26 Issue 1/2, p80 

    Mice homozygous for the gray tremor ( gt) mutation have a pleiotropic phenotype that includes pigmentation defects, megacolon, whole body tremors, sporadic seizures, hypo- and dys-myelination of the central nervous system (CNS) and peripheral nervous system, vacuolation of the CNS, and early...

  • All-you-can-eat: autophagy in neurodegeneration and neuroprotection. Jaeger, Philipp A.; Wyss-Coray, Tony // Molecular Neurodegeneration;2009, Vol. 4, p1 

    Autophagy is the major pathway involved in the degradation of proteins and organelles, cellular remodeling, and survival during nutrient starvation. Autophagosomal dysfunction has been implicated in an increasing number of diseases from cancer to bacterial and viral infections and more recently...

  • Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes. Louapre, Céline; Lubetzki, Catherine // Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1626 

    The article discusses debates about the causes of neurodegeneration in multiple sclerosis (MS), a type of central nervous system (CNS) inflammatory disease. Topics discussed include how inflammation and neurodegeneration interplay over the disease course, the potential factors that influence...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics